Skip to main content
Log in

Meningococcal B vax not recommended by UK's JCVI

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. the vaccine equivalent to NICE

References

  1. Joint Committee on Vaccination and Immunisation. JCVI interim position statement on use of Bexsero? meningococcal B vaccine in the UK. Internet Journal of Asthma, Allergy and Immunology : 24 Jul 2013. Available from: URL: https://www.gov.uk.

  2. Novartis. UK children remain unnecessarily at risk for life-threatening and disabling meningitis B disease, following JCVI interim recommendation on Novartis Bexsero(Rm) vaccine. Media Release : 24 Jul 2013. Available from: URL: http://www.novartis.com.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meningococcal B vax not recommended by UK's JCVI. PharmacoEcon Outcomes News 684, 10 (2013). https://doi.org/10.1007/s40274-013-0618-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0618-9

Navigation